Oncology is changing: the challenge of effectively assessing response within clinical trials in low-grade gliomas

  • Ilaria Imarisio | i.imarisio@smatteo.pv.it Department of Medical Oncology, IRCCS San Matteo University Hospital Foundation, Pavia, Italy.
  • Chiara Fumagalli Department of Neuroradiology, ‘Alessandro Manzoni’ Hospital, Lecco, Italy.

Abstract

The current WHO classification of primary central nervous system (CNS) tumors recognizes four separate tumor grades (I–IV), which can be grouped into low-grade (I and II) or high-grade (III and IV), depending on the absence or presence of high-grade histopathological features, such as microvascular proliferation and necrosis...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2011-06-30
Info
Issue
Section
Editorials
Statistics
  • Abstract views: 949

  • FULL TEXT: 133
How to Cite
Imarisio, I., & Fumagalli, C. (2011). Oncology is changing: the challenge of effectively assessing response within clinical trials in low-grade gliomas. Oncology Reviews, 5(2), 75-76. https://doi.org/10.4081/oncol.2011.19